Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/22/15  and contains information from public web pages and contributions from the ZoomInfo community.

Ms. Pamela A. Hay

Wrong Pamela A. Hay?

Co-founder and President

Visgo Therapeutics , Inc.
Phone: (617) ***-****  
Email: p***@***.com
Local Address:  Massachusetts , United States
Company Description: Visgo is developing best in class products to treat joint diseases, such as osteoarthritis. These products will be locally delivered using the Company's...   more
Background

Employment History

Education

  • law degree
    University of Wisconsin
  • Ms Hay
    Dyax Corp.
  • Ms Hay
    T Cell Sciences and Corporate Counsel
22 Total References
Web References
Pamela Hay PhD, Business ...
www.anelixistherapeutics.com, 31 Aug 2015 [cached]
Pamela Hay PhD, Business Development
...
Pamela Hay PhD, Business Development Dr. Hay has more than 25 years of business development and legal experience working in private and public biotechnology companies. She is a partner at Red Sky Partners, a business advisory firm to the health care industry that provides strategy and transaction advice and interim management services to private and public biotech and biopharma companies.
News & Headlines: Diversys Names Pamela Hay Chief Commercial Officer
www.otohns.net, 14 Mar 2014 [cached]
2001 NOV 12 - (NewsRx.com & NewsRx.net) -- Diversys Ltd., a protein engineering company, has hired business development executive Pamela Hay as chief commercial officer. Ms. Hay is considered an expert in the developing business opportunities in the fields of protein repertoires and protein engineering, and is a prolific negotiator of deals in this sector, according to the company.
...
Ms. Hay has more than 15 years of legal and business development experience with major biotechnology and pharmaceutical companies. With a degree in biology from Cornell and a law degree from the University of Wisconsin. She joined Dyax Corp. in 1996, where she rose to become senior vice president of corporate development and strategic opportunities. Within Dyax, Ms. Hay and her team negotiated over 75 collaboration, technology transfer and license agreements involving the company's phage display technology and product leads, managed the company's growing patent portfolio and legal needs, and helped lead the acquisition of new technologies. Ms. Hay will assume responsibility for the commercialization of Diversys' protein repertoire and engineering technologies for therapeutic, diagnostic and research use. In addition, she will be in charge of business development activities and management of Diversys intellectual property portfolio. Ms. Hay will be based in Diversys' new commercial office in Cambridge, Massachusetts. This article was prepared by Health & Medicine Week editors from staff and other reports.
PharmaLive
www.medadnews.com, 21 July 2001 [cached]
In the area of Corporate Development , Jack Morgan has joined the company as Senior Vice President , Corporate Development & Business Operations , and Pamela Hay , JD , has been appointed Senior Vice President , Corporate Development & Strategic Opportunities.
...
Ms. Hay joined Dyax in 1995 as Director of Licensing and Legal Affairs.Since that time , she conceived of and developed Dyax's very successful licensing programs.
NeuroHealing Pharmaceuticals Inc.
www.NHpharma.com, 16 Dec 2012 [cached]
Pamela Hay, J.D.
...
Pamela Hay, J.D. Pamela Hay is a business development and operations consultant for early stage biotechnology companies. She was Chief Commercial Officer at Domantis Ltd from 2001 until its acquisition by GSK in 2007, where she oversaw commercial development, including completion of major alliances with Abbott and BMS and additional deal negotiations that concluded the company's purchase. Previously, she was SVP, Corporate Development at Dyax Corp where she was responsible for the negotiation of more than 60 licenses and collaborations as well as the legal and IP functions. She has also held senior legal positions at T Cell Sciences and Biogen. Pamela has a JD from the University of Wisconsin and a BA in Biology from Cornell University.
Domantis
www.domantis.com, 11 Oct 2001 [cached]
DIVERSYS APPOINTS PAMELA HAY AS CHIEF COMMERCIAL OFFICER Former Senior Vice President of Dyax Joins Diversys
Cambridge, UK and Cambridge, USA, October 11, 2001 ... Diversys Limited, the protein engineering company, today announced that the prominent business development executive Pamela Hay has joined the company as Chief Commercial Officer.Ms Hay is considered an expert in the developing business opportunities in the fields of protein repertoires and protein engineering.She is also one of the more prolific negotiators of deals in this sector.
...
Pamela Hay has over 15 years of legal and business development experience with major biotechnology and pharmaceutical companies.With a degree in biology from Cornell and a law degree from the University of Wisconsin, Ms Hay worked for 5 years with Biogen as Corporate Counsel, where her responsibilities included managing the Company's patent estate and negotiation of business transactions.Ms Hay negotiated deals with SmithKline Beecham, Abbott Laboratories and with Merck for Biogen's hepatitis B patent estate.Ms Hay moved on to become General Counsel for T Cell Sciences, now Avant Immunotherapeutics, where she led the Company's legal and intellectual property activities.
Ms Hay joined Dyax Corp. in 1996, where she rose to become Senior Vice President of Corporate Development and Strategic Opportunities.Within Dyax, Ms Hay and her team negotiated over 75 collaboration, technology transfer and license agreements involving the Company's phage display technology and product leads, managed the Company's growing patent portfolio and legal needs, and helped lead the acquisition of new technologies.
Ms Hay will assume responsibility for the commercialisation of Diversys' protein repertoire and engineering technologies for therapeutic, diagnostic and research use.In addition, she will be in charge of business development activities and management of Diversys intellectual property portfolio.Ms Hay will be based in Diversys' new commercial office in Cambridge, Massachusetts in the USA.
Other People with the name "Hay":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304